ArticleFrontiers in reproductive health2026
SARS-CoV-2 and reproductive system: a scientometric study.
Article in Frontiers in reproductive health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Growing evidence, such as Long COVID, suggests that the interaction and underlying mechanism between SARS-CoV-2 and human cells, especially the long-term effect on the reproductive system, remain poorly understood, which should raise high public health concern. This study aimed to enhance understanding of the scientific development status in this field of the viral infection and the human genital system, and to explore key hotspots, thematic trends, major issues through a scientometric analysis of the relevant literature. Methods: This study retrieved the literature (2020-2025) on association between SARS-CoV-2 and the genital system from three databases, Web of Science Core Collection (WOSCC), Scopus, and PubMed, and performed comprehensive scientometric analysis of the literature to explore the bibliometric distribution, thematic trends and the major problems in this area using Bibliometrix/BiblioShiny. Results: A total of 2,354 publications from 2020 to 2025 were included in the analysis. The annual production of the publications has shown a declining trend since 2022, and is predicted to reach nearly zero by 2030. The most relevant journal was Mathematical Biosciences and Engineering. Wang X. and Wang Y. were the most prolific authors. China and the USA had the highest production of documents, while Sweden and Portugal had the highest average article citations. The most global cited document was "Cytokine Storm" (Fajgenbaum D, 2020, New Engl J Med). The most frequent keywords were covid-19, human, sars-cov-2, cell proliferation, pandemic, and basic reproduction number. Etiology, antigen presentation and sperm viability have been the newly emerging trend topics since 2025. A thematic map shows that the cluster of the keywords closely related to the impact of SARS-CoV-2 on reproductive system was located in the lower left quadrant, indicating that the themes associated with these keywords appeared early but remain underdeveloped. The USA, China, Italy and Germany conducted the most research collaborations, while most African, Latin American, and Asian countries were rarely involved. Conclusion: This report provides comprehensive insights, including the latest macroscopic perspectives, references, and practical guidance, for shaping research strategies, managing public health resources, and fostering scientific collaborations, featuring novel viewpoints that merit attention in the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.